|
lung cancer |
21 |
|
randomized controlled trial |
16 |
|
aerobic exercise |
13 |
|
mind-body intervention |
12 |
|
cancer |
10 |
|
chinese |
10 |
|
cognitive behavioral therapy |
10 |
|
family caregiver |
10 |
|
molecular tumour board |
10 |
|
next-generation sequencing |
10 |
|
precision oncology |
10 |
|
quality of life |
10 |
|
sequence-directed therapy |
10 |
|
advanced cancer |
9 |
|
cognitive behavioural therapy |
9 |
|
family caregivers |
9 |
|
non-small cell lung cancer |
9 |
|
targeted therapy |
9 |
|
aerobic exercises |
8 |
|
bintrafusp alfa |
8 |
|
cancer patients |
8 |
|
correlative biomarkers |
8 |
|
efficacy |
8 |
|
mind-body exercises |
8 |
|
poor sleep |
8 |
|
recurrent or metastatic nasopharyngeal cancer |
8 |
|
safety |
8 |
|
adolescent |
7 |
|
adult |
7 |
|
advanced lung cancer |
7 |
|
aged |
7 |
|
alcoholism |
7 |
|
anxiety disorder |
7 |
|
cognitive function |
7 |
|
dyspnea |
7 |
|
tai chi |
7 |
|
comparative effectiveness |
6 |
|
family |
6 |
|
intervention research |
6 |
|
lungquality of life |
6 |
|
palliative care |
6 |
|
radiotherapy |
6 |
|
rct |
6 |
|
survival |
6 |
|
tai-chi |
6 |
|
her2+ breast cancer |
5 |
|
her2-targeted therapy |
5 |
|
metastatic brain tumours |
5 |
|
tyrosine kinase inhibitor |
5 |
|
acupressure |
4 |
|
end-of-life care |
4 |
|
fatigue |
4 |
|
insomnia |
4 |
|
multidisciplinary |
4 |
|
pain |
4 |
|
spinal metastases |
4 |
|
survival prediction |
4 |
|
brachytherapy |
3 |
|
chemotherapy |
3 |
|
do-not-resuscitate |
3 |
|
end of life |
3 |
|
hong kong |
3 |
|
hospice |
3 |
|
local recurrence |
3 |
|
nasopharyngeal cancer |
3 |
|
nasopharyngectomy |
3 |
|
oncology |
3 |
|
pain control |
3 |
|
patient outcome assessment |
3 |
|
prognostication |
3 |
|
radiation therapy |
3 |
|
reirradiation |
3 |
|
hypertension. |
2 |
|
magnetic resonance imaging |
2 |
|
neurofibroma - diagnosis - etiology |
2 |
|
obesity. |
2 |
|
peripheral nervous system neoplasms - diagnosis - etiology |
2 |
|
radiotherapy, conformal - adverse effects |
2 |
|
sodium channels. |
2 |
|
spinal nerve roots - pathology |
2 |
|
braf-mek inhibitors |
1 |
|
brafv600e mutation |
1 |
|
brain metastases |
1 |
|
carcinoma |
1 |
|
clergy |
1 |
|
clinical decision making |
1 |
|
gamma knife system |
1 |
|
glioblastoma |
1 |
|
hepatitis b virus |
1 |
|
hepatocellular |
1 |
|
malignant epidural spinal cord compression (mscc) |
1 |
|
metastases |
1 |
|
modified bauer score |
1 |
|
modified tokuhashi score |
1 |
|
nasopharyngeal carcinoma |
1 |
|
neurocognitive function |
1 |
|
neurosurgery |
1 |
|
palliative radiotherapy |
1 |
|
pastoral care |
1 |
|
prognosis |
1 |
|
pulsed steroid |
1 |
|
radiation therapy (rt) |
1 |
|
radiosurgery |
1 |
|
religion |
1 |
|
serious illness |
1 |
|
southern chinese |
1 |
|
spine |
1 |
|
spine radiation |
1 |
|
spirituality |
1 |
|
stereotactic radiosurgery |
1 |
|
stereotactic radiosurgery (srs) |
1 |
|
targeted therapies |
1 |
|
temporal lobe necrosis |
1 |
|
whole brain radiation therapy |
1 |
|
whole brain radiation therapy (wbrt) |
1 |
